Steven Alan Mitnick, MD
Internal Medicine · Los Altos
- Medicare standing
- 2 flags on the record
- Listed below.
- Plans that list them
- Not verified
- Not the same as out of network.
- Offices
- 2
On the public record
- Medicare does not list them as allowed to order and refer
- California licence: Delinquent
Offices
2 locations
Plan participation
Not verified
We could not verify current plan participation for this doctor. This does not mean they are out of network. Call Dr. Mitnick’s office to ask if they take your plan before you enroll.
California Medical Board record
Licence G51282 · Delinquent
Licence status: Delinquent · since 1983 · expires 2025-07-31 · University of California, Irvine College of Medicine.
License renewal fee has not been paid. No practice is permitted.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Original Medicare doctor bills
$165,509
Medicare paid this office $165,509 for 8,588 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Insertion of needle into vein for collection of blood sample | 8,565 | $153,784 | $9 |
| Sarscov2 vac 50 mcg/0.5ml im | 30 | $4,753 | $158 |
| Return visit (30+ min) | 19 | $1,916 | $101 |
| Influenza vaccine, inactivated | 21 | $1,718 | $82 |
| Admn sarscov2 vacc 1 dose | 30 | $1,458 | $49 |
See all 7 services
| Insertion of needle into vein for collection of blood sample | 8,565 | $153,784 | $9 |
| Sarscov2 vac 50 mcg/0.5ml im | 30 | $4,753 | $158 |
| Return visit (30+ min) | 19 | $1,916 | $101 |
| Influenza vaccine, inactivated | 21 | $1,718 | $82 |
| Admn sarscov2 vacc 1 dose | 30 | $1,458 | $49 |
| Administration of influenza virus vaccine | 20 | $731 | $37 |
| Short return visit (20+ min) | 11 | $631 | $57 |
Who their Medicare patients are
8,588 Original Medicare patients in 2024. Average age 75 · Under 65 4% · 85 and older 11% · Women 59% · Also on Medicaid 10% · Health risk score 1.09. At or below the middle of the specialty; the typical internal medicine clinician is at 1.76.
Conditions among them: High blood pressure 65% · Coronary heart disease 24% · Diabetes 21% · Chronic kidney disease 19% · Atrial fibrillation 18% · Cancer 17% · Depression 17% · Heart failure 13% · COPD 11% · Stroke 6% · Dementia 5%.
The office billed $393,371, Medicare allowed $167,031 and paid $165,509; for 17,920 services of 13 kinds; $6,471 of it was for drugs given in the office and $159,038 for care.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 8,588 | 17,920 | 75 | 1.09 | $393,371 | $165,509 |
| 2023 | 10,091 | 28,603 | 74 | 1.03 | $1,002,719 | $468,602 |
| 2022 | 9,644 | 25,840 | 74 | 1.01 | $697,118 | $138,699 |
| 2021 | 19,462 | 49,845 | 75 | 0.95 | $2,195,051 | $791,995 |
| 2020 | 321 | 390 | 74 | 1.47 | $9,532 | $1,417 |
| 2019 | 41 | 149 | 77 | 1.81 | $7,554 | $1,784 |
| 2018 | 78 | 171 | 74 | 2.13 | $11,676 | $2,890 |
| 2017 | 385 | 780 | 73 | 1.78 | $111,151 | $27,819 |
| 2016 | 198 | 285 | 72 | 1.72 | $59,043 | $17,575 |
| 2015 | 55 | 67 | 75 | 1.99 | $6,752 | $1,810 |
| 2014 | 26 | 29 | 68 | 2.30 | $7,367 | $2,201 |
| 2013 | 17 | 18 | 69 | 2.23 | $4,211 | $1,290 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 10 services
| Insertion of needle into vein for collection of blood sample | 9,723 | $211,967 | $8 |
| Sarscov2 vac 50 mcg/0.5ml im | 952 | $136,136 | $143 |
| Admn sarscov2 vacc 1 dose | 952 | $43,364 | $46 |
| Influenza vaccine, quadrivalent inactivated, 0.5 ml dosage | 523 | $39,638 | $76 |
| Administration of influenza virus vaccine | 539 | $18,423 | $34 |
| Adm sarscv2 bvl 50mcg/.5ml a | 124 | $5,648 | $46 |
| Adm sarscv2 bvl 30mcg/.3ml a | 102 | $4,646 | $46 |
| Return visit (30+ min) | 44 | $4,637 | $101 |
| Short return visit (20+ min) | 23 | $1,616 | $67 |
| Influenza vaccine, quadrivalent, preservative free, 0.5 ml dosage | 20 | $438 | $22 |
2022: 12 services
| Insertion of needle into vein for collection of blood sample | 9,385 | $72,370 | $3 |
| Adm sarscv2 bvl 30mcg/.3ml a | 536 | $23,811 | $44 |
| Influenza vaccine, quadrivalent inactivated, 0.5 ml dosage | 147 | $10,327 | $70 |
| Intramuscular administration of single severe acute respiratory syndrome coronavirus 2 (covid-19) vaccine, mrna-lnp, spike protein, preservative free, 30 mcg/0.3ml dosage, diluent reconstituted; first dose | 142 | $6,370 | $45 |
| Adm sarscv2 bvl 50mcg/.5ml a | 142 | $6,296 | $44 |
| Administration of influenza virus vaccine | 149 | $4,986 | $33 |
| Return visit (30+ min) | 35 | $3,766 | $105 |
| Intramuscular administration of single severe acute respiratory syndrome coronavirus 2 (covid-19) vaccine, mrna-lnp, spike protein, preservative free, 30 mcg/0.3ml dosage, tris-sucrose formulation; booster dose | 76 | $3,380 | $44 |
| Short return visit (20+ min) | 37 | $2,448 | $66 |
| Intramuscular administration of single severe acute respiratory syndrome coronavirus 2 (covid-19) vaccine, mrna-lnp, spike protein, preservative free, 30 mcg/0.3ml dosage, diluent reconstituted; booster dose | 30 | $1,356 | $45 |
| Intramuscular administration of single severe acute respiratory syndrome coronavirus 2 (covid-19) vaccine, mrna-lnp, spike protein, preservative free, 30 mcg/0.3ml dosage, diluent reconstituted; second dose | 12 | $538 | $45 |
| Blood test, clotting time | 11 | $220 | $4 |
2021: 7 services
| Intramuscular administration of single severe acute respiratory syndrome coronavirus 2 (covid-19) vaccine, mrna-lnp, spike protein, preservative free, 100 mcg/0.5ml dosage; second dose | 9,033 | $313,417 | $35 |
| Intramuscular administration of single severe acute respiratory syndrome coronavirus 2 (covid-19) vaccine, mrna-lnp, spike protein, preservative free, 100 mcg/0.5ml dosage; first dose | 9,598 | $203,050 | $21 |
| Intramuscular administration of single severe acute respiratory syndrome coronavirus 2 (covid-19) vaccine, mrna-lnp, spike protein, preservative free, 30 mcg/0.3ml dosage, diluent reconstituted; second dose | 2,919 | $107,758 | $37 |
| Intramuscular administration of single severe acute respiratory syndrome coronavirus 2 (covid-19) vaccine, mrna-lnp, spike protein, preservative free, 30 mcg/0.3ml dosage, diluent reconstituted; first dose | 3,220 | $81,658 | $25 |
| Insertion of needle into vein for collection of blood sample | 9,359 | $73,474 | $3 |
| Intramuscular administration of single severe acute respiratory syndrome coronavirus 2 (covid-19) vaccine, mrna-lnp, spike protein, preservative free, 30 mcg/0.3ml dosage, diluent reconstituted; booster dose | 236 | $10,620 | $45 |
| Blood test, clotting time | 15 | $463 | $4 |
2020: 2 services
| Insertion of needle into vein for collection of blood sample | 298 | $906 | $3 |
| Blood test, clotting time | 20 | $364 | $4 |
2019: 1 service
| Blood test, clotting time | 29 | $582 | $4 |
2018: 1 service
| Blood test, clotting time | 55 | $698 | $5 |
2017: 8 services
| Short return visit (20+ min) | 250 | $13,349 | $45 |
| Return visit (30+ min) | 79 | $6,062 | $71 |
| Transitional care management services for problem of high complexity | 15 | $3,145 | $185 |
| Transitional care management services for problem of at least moderate complexity | 14 | $1,833 | $122 |
| Blood test, clotting time | 47 | $370 | $5 |
| Injection of drug or substance under skin or into muscle | 19 | $333 | $18 |
| Automated urinalysis test | 37 | $112 | $3 |
| Levalbuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, concentrated form, 0.5 mg | 15 | $5 | None |
2016: 4 services
| Short return visit (20+ min) | 122 | $7,622 | $57 |
| Return visit (30+ min) | 60 | $5,276 | $85 |
| Transitional care management services for problem of high complexity | 13 | $2,431 | $187 |
| Automated urinalysis test | 16 | $48 | $3 |
2015: 2 services
| Short return visit (20+ min) | 17 | $947 | $56 |
| Blood test, clotting time | 35 | $231 | $5 |
Medicaid work
$8,762 in 2023
Medicaid paid $8,762 for 114 billed services this clinician did in 2023, up to 33 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, mRNA-LNP, 50 mcg/0.5 mL dosage, for intramuscular use | 44 | $6,420 |
| Immunization administration by intramuscular injection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, single dose | 47 | $1,880 |
| Influenza virus vaccine, quadrivalent (IIV4), split virus, preservative free, 0.5 mL dosage, for intramuscular use | 23 | $462 |
| 2023 | 114 | 3 | 33 | $8,762 |
| 2022 | 42 | 1 | 41 | $0 |
| 2021 | 1,345 | 4 | 186 | $50,562 |
See the largest Medicaid services in earlier years
2022
| Handling and/or conveyance of specimen for transfer from physician office to laboratory | 42 | $0 |
2021
| Immunization administration by intramuscular injection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, mRNA-LNP, spike protein, preservative free, 30 mcg/0.3 mL dosage, diluent reconstituted; first dose | 350 | $13,481 |
| Immunization administration by intramuscular injection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, mRNA-LNP, spike protein, preservative free, 30 mcg/0.3 mL dosage, diluent reconstituted; second dose | 332 | $13,103 |
| Immunization administration by intramuscular injection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, mRNA-LNP, spike protein, preservative free, 100 mcg/0.5 mL dosage; second dose | 323 | $12,129 |
| Immunization administration by intramuscular injection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, mRNA-LNP, spike protein, preservative free, 100 mcg/0.5 mL dosage; first dose | 340 | $11,849 |
Professional record
- NPI
- 1548285950
- Licence
- CA G51282California G51282: Delinquent · expires 2025-07-31
- Trained
- University of California, Irvine, California College of Medicine, 1982
- Gender
- Male
More record details
- Sole proprietor
- No
- Medicaid ID
- CA 00G512820
- Taxonomy
- Federal specialty code 207ZP0102X (207ZP0102X); Internal medicine (207R00000X)
- Mailing address
- 325 Distel Cir, Los Altos, CA, 94022
- NPI first listed
- 2006-07-13
- NPI last updated
- 2021-04-29
- NPI record certified
- 2021-04-29
This is when the NPI record was last certified, not a medical board exam.
Extra NPI addresses: 600 Coffee Rd, Modesto, CA, 95355 · 50 Mark West Springs Rd, Santa Rosa, CA, 95403